TY - JOUR AU - Farrar, M. A. AU - Kiernan, M. C. PY - 2015 DA - 2015// TI - The genetics of spinal muscular atrophy: progress and challenges JO - Neurotherapeutics VL - 12 UR - https://doi.org/10.1007/s13311-014-0314-x DO - 10.1007/s13311-014-0314-x ID - Farrar2015 ER - TY - JOUR AU - Kolb, S. J. AU - Kissel, J. T. PY - 2015 DA - 2015// TI - Spinal muscular atrophy JO - Neurol Clin VL - 33 UR - https://doi.org/10.1016/j.ncl.2015.07.004 DO - 10.1016/j.ncl.2015.07.004 ID - Kolb2015 ER - TY - JOUR AU - Arnold, W. D. AU - Kassar, D. AU - Kissel, J. T. PY - 2015 DA - 2015// TI - Spinal muscular atrophy: Diagnosis and management in a new therapeutic era JO - Muscle Nerve VL - 51 UR - https://doi.org/10.1002/mus.24497 DO - 10.1002/mus.24497 ID - Arnold2015 ER - TY - JOUR AU - Haaker, G. AU - Fujak, A. PY - 2013 DA - 2013// TI - Proximal spinal muscular atrophy: current orthopedic perspective JO - Appl Clin Genet VL - 6 ID - Haaker2013 ER - TY - JOUR AU - D'Amico, A. AU - Mercuri, E. AU - Tiziano, F. D. AU - Bertini, E. PY - 2011 DA - 2011// TI - Spinal muscular atrophy JO - Orphanet J Rare Dis VL - 6 UR - https://doi.org/10.1186/1750-1172-6-71 DO - 10.1186/1750-1172-6-71 ID - D'Amico2011 ER - TY - JOUR AU - Lefebvre, S. AU - Bürglen, L. AU - Reboullet, S. AU - Clermont, O. AU - Burlet, P. AU - Viollet, L. PY - 1995 DA - 1995// TI - Identification and characterization of a spinal muscular atrophy-determining gene JO - Cell VL - 80 UR - https://doi.org/10.1016/0092-8674(95)90460-3 DO - 10.1016/0092-8674(95)90460-3 ID - Lefebvre1995 ER - TY - JOUR AU - Lunn, M. R. AU - Wang, C. H. PY - 2008 DA - 2008// TI - Spinal muscular atrophy JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60921-6 DO - 10.1016/S0140-6736(08)60921-6 ID - Lunn2008 ER - TY - JOUR AU - Larkindale, J. AU - Yang, W. AU - Hogan, P. F. AU - Simon, C. J. AU - Zhang, Y. AU - Jain, A. PY - 2014 DA - 2014// TI - Cost of illness for neuromuscular diseases in the United States JO - Muscle Nerve VL - 49 UR - https://doi.org/10.1002/mus.23942 DO - 10.1002/mus.23942 ID - Larkindale2014 ER - TY - STD TI - Group L. Cost of amyotrophic lateral sclerosis, muscular dystrophy, and spinal muscular atrophy in the United States: final report for Muscular Dystrophy Association. 2012. ID - ref9 ER - TY - JOUR AU - Droege, M. AU - Sproule, D. AU - Arjunji, R. AU - Gauthier-Loiselle, M. AU - Cloutier, M. AU - Dabbous, O. PY - 2020 DA - 2020// TI - Economic burden of spinal muscular atrophy in the United States: a contemporary assessment JO - J Med Econ VL - 23 UR - https://doi.org/10.1080/13696998.2019.1646263 DO - 10.1080/13696998.2019.1646263 ID - Droege2020 ER - TY - JOUR AU - Armstrong, E. P. AU - Malone, D. C. AU - Yeh, W. -. S. AU - Dahl, G. J. AU - Lee, R. L. AU - Sicignano, N. PY - 2016 DA - 2016// TI - The economic burden of spinal muscular atrophy JO - J Med Econ VL - 19 UR - https://doi.org/10.1080/13696998.2016.1198355 DO - 10.1080/13696998.2016.1198355 ID - Armstrong2016 ER - TY - JOUR AU - Tan, H. AU - Gu, T. AU - Chen, E. AU - Punekar, R. AU - Shieh, P. B. PY - 2019 DA - 2019// TI - Healthcare utilization, costs of care, and mortality among patients with spinal muscular atrophy JO - J Health Econ Outcomes Res VL - 6 UR - https://doi.org/10.36469/63185 DO - 10.36469/63185 ID - Tan2019 ER - TY - JOUR AU - Cardenas, J. AU - Menier, M. AU - Heitzer, M. D. AU - Sproule, D. M. PY - 2019 DA - 2019// TI - High healthcare resource use in hospitalized patients with a diagnosis of spinal muscular atrophy type 1 (SMA1): retrospective analysis of the kids’ inpatient database (KID) JO - Pharmacoecon Open VL - 3 UR - https://doi.org/10.1007/s41669-018-0093-0 DO - 10.1007/s41669-018-0093-0 ID - Cardenas2019 ER - TY - JOUR AU - López-Bastida, J. AU - Peña-Longobardo, L. M. AU - Aranda-Reneo, I. AU - Tizzano, E. AU - Sefton, M. AU - Oliva-Moreno, J. PY - 2017 DA - 2017// TI - Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain JO - Orphanet J Rare Dis VL - 12 UR - https://doi.org/10.1186/s13023-017-0695-0 DO - 10.1186/s13023-017-0695-0 ID - López-Bastida2017 ER - TY - JOUR AU - Farrar, M. A. AU - Carey, K. A. AU - Paguinto, S. -. G. AU - Chambers, G. AU - Kasparian, N. A. PY - 2018 DA - 2018// TI - Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives JO - BMJ Open VL - 8 UR - https://doi.org/10.1136/bmjopen-2017-020907 DO - 10.1136/bmjopen-2017-020907 ID - Farrar2018 ER - TY - JOUR AU - Kruitwagen-van Reenen, E. T. AU - Pol, L. AU - Schroder, C. AU - Wadman, R. I. AU - Berg, L. H. AU - Visser-Meily, J. M. A. PY - 2018 DA - 2018// TI - Social participation of adult patients with spinal muscular atrophy: frequency, restrictions, satisfaction, and correlates JO - Muscle Nerve VL - 58 UR - https://doi.org/10.1002/mus.26201 DO - 10.1002/mus.26201 ID - Kruitwagen-van Reenen2018 ER - TY - JOUR AU - Nance, J. R. PY - 2020 DA - 2020// TI - Spinal muscular atrophy JO - Continuum (Minneap Minn) VL - 26 ID - Nance2020 ER - TY - JOUR AU - Finkel, R. S. AU - Mercuri, E. AU - Darras, B. T. AU - Connolly, A. M. AU - Kuntz, N. L. AU - Kirschner, J. PY - 2017 DA - 2017// TI - Nusinersen versus sham control in infantile-onset spinal muscular atrophy JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1702752 DO - 10.1056/NEJMoa1702752 ID - Finkel2017 ER - TY - STD TI - (FDA) UFDA. Spinraza prescribing information 2016 [updated December 2016]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf ID - ref19 ER - TY - JOUR AU - Strauss, K. A. AU - Carson, V. J. AU - Brigatti, K. W. AU - Young, M. AU - Robinson, D. L. AU - Hendrickson, C. PY - 2018 DA - 2018// TI - Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy JO - J Pediatr Orthop VL - 38 UR - https://doi.org/10.1097/BPO.0000000000001247 DO - 10.1097/BPO.0000000000001247 ID - Strauss2018 ER - TY - JOUR AU - Waldrop, M. A. AU - Karingada, C. AU - Storey, M. A. AU - Powers, B. AU - Iammarino, M. A. AU - Miller, N. F. PY - 2020 DA - 2020// TI - Gene therapy for spinal muscular atrophy: safety and early outcomes JO - Pediatrics VL - 146 UR - https://doi.org/10.1542/peds.2020-0729 DO - 10.1542/peds.2020-0729 ID - Waldrop2020 ER - TY - JOUR AU - Mendell, J. R. AU - Al-Zaidy, S. AU - Shell, R. AU - Arnold, W. D. AU - Rodino-Klapac, L. R. AU - Prior, T. W. PY - 2017 DA - 2017// TI - Single-dose gene-replacement therapy for spinal muscular atrophy JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1706198 DO - 10.1056/NEJMoa1706198 ID - Mendell2017 ER - TY - JOUR AU - Dhillon, S. PY - 2020 DA - 2020// TI - Risdiplam: first approval JO - Drugs VL - 80 UR - https://doi.org/10.1007/s40265-020-01410-z DO - 10.1007/s40265-020-01410-z ID - Dhillon2020 ER - TY - JOUR AU - Ratni, H. AU - Ebeling, M. AU - Baird, J. AU - Bendels, S. AU - Bylund, J. AU - Chen, K. S. PY - 2018 DA - 2018// TI - Discovery of risdiplam, a selective survival of motor neuron-2 ( SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA) JO - J Med Chem VL - 61 UR - https://doi.org/10.1021/acs.jmedchem.8b00741 DO - 10.1021/acs.jmedchem.8b00741 ID - Ratni2018 ER - TY - JOUR AU - Ploeg, A. T. PY - 2017 DA - 2017// TI - The dilemma of two innovative therapies for spinal muscular atrophy JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMe1712106 DO - 10.1056/NEJMe1712106 ID - Ploeg2017 ER - TY - JOUR AU - Climent, E. AU - Benaiges, D. AU - Pedro-Botet, J. AU - Goday, A. AU - Sola, I. AU - Ramon, J. M. PY - 2018 DA - 2018// TI - Laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of lipid effects at one year postsurgery JO - Minerva Endocrinol VL - 43 ID - Climent2018 ER - TY - JOUR AU - Mesfin, A. AU - Sponseller, P. D. AU - Leet, A. I. PY - 2012 DA - 2012// TI - Spinal muscular atrophy: manifestations and management JO - J Am Acad Orthop Surg VL - 20 UR - https://doi.org/10.5435/JAAOS-20-06-393 DO - 10.5435/JAAOS-20-06-393 ID - Mesfin2012 ER - TY - JOUR AU - Qian, Y. AU - McGraw, S. AU - Henne, J. AU - Jarecki, J. AU - Hobby, K. AU - Yeh, W. -. S. PY - 2015 DA - 2015// TI - Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study JO - BMC Neurology VL - 15 UR - https://doi.org/10.1186/s12883-015-0473-3 DO - 10.1186/s12883-015-0473-3 ID - Qian2015 ER - TY - JOUR AU - Wang, C. H. AU - Finkel, R. S. AU - Bertini, E. S. AU - Schroth, M. AU - Simonds, A. AU - Wong, B. PY - 2007 DA - 2007// TI - Consensus statement for standard of care in spinal muscular atrophy JO - J Child Neurol VL - 22 UR - https://doi.org/10.1177/0883073807305788 DO - 10.1177/0883073807305788 ID - Wang2007 ER - TY - JOUR AU - Reed Johnson, F. AU - Lancsar, E. AU - Marshall, D. AU - Kilambi, V. AU - Muhlbacher, A. AU - Regier, D. A. PY - 2013 DA - 2013// TI - Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force JO - Value Health VL - 16 UR - https://doi.org/10.1016/j.jval.2012.08.2223 DO - 10.1016/j.jval.2012.08.2223 ID - Reed Johnson2013 ER - TY - JOUR AU - Bridges, J. F. AU - Hauber, A. B. AU - Marshall, D. AU - Lloyd, A. AU - Prosser, L. A. AU - Regier, D. A. PY - 2011 DA - 2011// TI - Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2010.11.013 DO - 10.1016/j.jval.2010.11.013 ID - Bridges2011 ER - TY - JOUR AU - Hauber, A. B. AU - Arden, N. K. AU - Mohamed, A. F. AU - Johnson, F. R. AU - Peloso, P. M. AU - Watson, D. J. PY - 2013 DA - 2013// TI - A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis JO - Osteoarthritis Cartilage VL - 21 UR - https://doi.org/10.1016/j.joca.2012.11.007 DO - 10.1016/j.joca.2012.11.007 ID - Hauber2013 ER - TY - JOUR AU - Harris, P. A. AU - Taylor, R. AU - Thielke, R. AU - Payne, J. AU - Gonzalez, N. AU - Conde, J. G. PY - 2009 DA - 2009// TI - Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support JO - J Biomed Inform VL - 42 UR - https://doi.org/10.1016/j.jbi.2008.08.010 DO - 10.1016/j.jbi.2008.08.010 ID - Harris2009 ER - TY - BOOK AU - Louviere, J. AU - Hensher, D. A. AU - Swait, J. D. PY - 2000 DA - 2000// TI - Stated choice methods: analysis and application PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511753831 DO - 10.1017/CBO9780511753831 ID - Louviere2000 ER - TY - JOUR AU - Bekker-Grob, E. W. AU - Donkers, B. AU - Jonker, M. F. AU - Stolk, E. A. PY - 2015 DA - 2015// TI - Sample size requirements for discrete-choice experiments in healthcare: a practical guide JO - Patient VL - 8 UR - https://doi.org/10.1007/s40271-015-0118-z DO - 10.1007/s40271-015-0118-z ID - Bekker-Grob2015 ER - TY - JOUR AU - Chaugule, S. S. AU - Hay, J. W. AU - Young, G. PY - 2015 DA - 2015// TI - Understanding patient preferences and willingness to pay for hemophilia therapies JO - Patient Prefer Adherence VL - 9 UR - https://doi.org/10.2147/PPA.S92985 DO - 10.2147/PPA.S92985 ID - Chaugule2015 ER - TY - JOUR AU - Kuhfeld, W. F. AU - Tobias, R. D. PY - 2005 DA - 2005// TI - Large factorial designs for product engineering and marketing research applications JO - Technometrics VL - 47 UR - https://doi.org/10.1198/004017004000000653 DO - 10.1198/004017004000000653 ID - Kuhfeld2005 ER - TY - JOUR AU - Huber, J. AU - Zwerina, K. PY - 1996 DA - 1996// TI - The importance of utility balance in efficient choice designs JO - J Mark Res VL - 33 UR - https://doi.org/10.1177/002224379603300305 DO - 10.1177/002224379603300305 ID - Huber1996 ER - TY - JOUR AU - Rouault, F. AU - Christie-Brown, V. AU - Broekgaarden, R. AU - Gusset, N. AU - Henderson, D. AU - Marczuk, P. PY - 2017 DA - 2017// TI - Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients JO - Neuromuscul Disord VL - 27 UR - https://doi.org/10.1016/j.nmd.2017.01.018 DO - 10.1016/j.nmd.2017.01.018 ID - Rouault2017 ER - TY - JOUR AU - Cruz, R. AU - Belter, L. AU - Wasnock, M. AU - Nazarelli, A. AU - Jarecki, J. PY - 2019 DA - 2019// TI - Evaluating benefit-risk decision-making in spinal muscular atrophy: a first-ever study to assess risk tolerance in the SMA patient community JO - Clin Ther. VL - 41 UR - https://doi.org/10.1016/j.clinthera.2019.03.012 DO - 10.1016/j.clinthera.2019.03.012 ID - Cruz2019 ER - TY - JOUR AU - Pacione, M. AU - Siskind, C. E. AU - Day, J. W. AU - Tabor, H. K. PY - 2019 DA - 2019// TI - Perspectives on Spinraza (Nusinersen) treatment study: views of individuals and parents of children diagnosed with spinal muscular atrophy JO - J Neuromuscul Dis VL - 6 UR - https://doi.org/10.3233/JND-180330 DO - 10.3233/JND-180330 ID - Pacione2019 ER -